Early recognition of cardiovascular disease is the biggest challenge. Helping patients as early as possible will lower the disease burden and provides big improvements to quality of life. For early recognition we need excellent science. Dutch cardiovascular researchers rank among the best in the world. Existing public-private consortia have already proven to be successful in the last decades.
The Dutch CardioVascular Alliance will work from this strong foundation by investing in breakthrough science in consortia that lay the basis for cardiovascular solutions.Learn more about our consortia
Chair of Research policy
Prof. dr. Wiek van Gilst
Professor of Cardiovascular and Clinical Pharmacology at University Medical Center Groningen